MedPath

TVMR With the Innovalve System Trial - Early Feasibility Study

Not Applicable
Recruiting
Conditions
Mitral Valve Regurgitation (Degenerative or Functional)
Interventions
Device: Innovalve MR system
Registration Number
NCT04919980
Lead Sponsor
Edwards Lifesciences
Brief Summary

Study to evaluate the safety and performance of the Innovalve mitral valve replacement system

Detailed Description

The study is a multi-center, First-In-Human, prospective, single arm early feasibility study to evaluate the safety and performance of the Innovalve mitral valve replacement system

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
65
Inclusion Criteria
  • Clinically significant, symptomatic mitral regurgitation
  • High risk for open-heart surgery
  • Meets anatomical criteria
Exclusion Criteria
  • Unsuitable anatomy
  • Patient is inoperable
  • EF<25%

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
TreatmentInnovalve MR systemMV replacement with Innovalve MR system
Primary Outcome Measures
NameTimeMethod
Absence of implant or delivery related serious adverse events at 30 days30 days

Absence of implant or delivery related serious adverse events

Secondary Outcome Measures
NameTimeMethod
Technical successProcedure
Procedural success30 days
NYHA functional class30 days, 3, 6, 12 months and annually up to 5 years
Six-minute walk test30 days, 3, 6, 12 months and annually up to 5 years
Quality of life improvement (KCCQ-12)30 days, 3, 6, 12 months and annually up to 5 years
Reduction in MR grade30 days, 3, 6, 12 months and annually up to 5 years

Trial Locations

Locations (12)

Piedmont Heart Institute

🇺🇸

Atlanta, Georgia, United States

University of Michigan Hospital and Health Systems

🇺🇸

Ann Arbor, Michigan, United States

Cornell

🇺🇸

New York, New York, United States

Oregon Health & Science Universtiy

🇺🇸

Portland, Oregon, United States

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Cedars-Sinai

🇺🇸

Los Angeles, California, United States

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

NewYork-Presbyterian / Columbia University

🇺🇸

New York, New York, United States

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

OhioHealth Research Institute

🇺🇸

Columbus, Ohio, United States

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

Swedish Medical Center

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath